Compare SUVEN LIFE with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs DR. REDDYS LAB - Comparison Results

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES DR. REDDYS LAB SUVEN LIFESCIENCES/
DR. REDDYS LAB
 
P/E (TTM) x 19.5 21.5 90.5% View Chart
P/BV x 3.9 3.2 122.5% View Chart
Dividend Yield % 0.5 0.7 72.8%  

Financials

 SUVEN LIFESCIENCES   DR. REDDYS LAB
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-19
DR. REDDYS LAB
Mar-19
SUVEN LIFESCIENCES/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs3382,875 11.7%   
Low Rs1691,888 9.0%   
Sales per share (Unadj.) Rs52.1930.2 5.6%  
Earnings per share (Unadj.) Rs6.8117.4 5.8%  
Cash flow per share (Unadj.) Rs8.6185.8 4.6%  
Dividends per share (Unadj.) Rs1.5020.00 7.5%  
Dividend yield (eoy) %0.60.8 70.4%  
Book value per share (Unadj.) Rs65.3844.4 7.7%  
Shares outstanding (eoy) m127.28166.07 76.6%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x4.92.6 190.0%   
Avg P/E ratio x37.120.3 183.0%  
P/CF ratio (eoy) x29.612.8 230.8%  
Price / Book Value ratio x3.92.8 137.7%  
Dividend payout %22.017.0 128.9%   
Avg Mkt Cap Rs m32,272395,496 8.2%   
No. of employees `0001.122.0 4.9%   
Total wages/salary Rs m66133,562 2.0%   
Avg. sales/employee Rs Th6,132.27,032.8 87.2%   
Avg. wages/employee Rs Th611.11,527.9 40.0%   
Avg. net profit/employee Rs Th803.5887.7 90.5%   
INCOME DATA
Net Sales Rs m6,635154,482 4.3%  
Other income Rs m2423,375 7.2%   
Total revenues Rs m6,877157,857 4.4%   
Gross profit Rs m1,60431,782 5.0%  
Depreciation Rs m22111,348 2.0%   
Interest Rs m38889 4.2%   
Profit before tax Rs m1,58722,920 6.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m0438 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7183,858 18.6%   
Profit after tax Rs m86919,500 4.5%  
Gross profit margin %24.220.6 117.5%  
Effective tax rate %45.216.8 268.7%   
Net profit margin %13.112.6 103.8%  
BALANCE SHEET DATA
Current assets Rs m6,232111,101 5.6%   
Current liabilities Rs m1,49058,973 2.5%   
Net working cap to sales %71.533.7 211.8%  
Current ratio x4.21.9 222.0%  
Inventory Days Days8679 108.9%  
Debtors Days Days8394 87.7%  
Net fixed assets Rs m4,043101,245 4.0%   
Share capital Rs m127830 15.3%   
"Free" reserves Rs m8,183139,406 5.9%   
Net worth Rs m8,310140,236 5.9%   
Long term debt Rs m1822,000 0.1%   
Total assets Rs m10,389224,656 4.6%  
Interest coverage x43.126.8 161.0%   
Debt to equity ratio x00.2 1.4%  
Sales to assets ratio x0.60.7 92.9%   
Return on assets %8.79.1 96.2%  
Return on equity %10.513.9 75.2%  
Return on capital %19.514.9 130.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,62288,673 6.3%   
Fx outflow Rs m1,79919,104 9.4%   
Net fx Rs m3,82269,569 5.5%   
CASH FLOW
From Operations Rs m35628,704 1.2%  
From Investments Rs m-279-7,727 3.6%  
From Financial Activity Rs m-225-21,326 1.1%  
Net Cashflow Rs m-148-314 47.2%  

Share Holding

Indian Promoters % 63.4 25.5 248.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 5.4 -  
FIIs % 0.0 35.3 -  
ADR/GDR % 0.0 18.5 -  
Free float % 36.5 15.3 238.6%  
Shareholders   37,287 75,885 49.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   STRIDES PHARMA SCIENCE  AJANTA PHARMA  UNICHEM LAB  ALEMBIC PHARMA  ELDER PHARMA  

Compare SUVEN LIFESCIENCES With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views on News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFE Announces Quarterly Results (3QFY19); Net Profit Down 27.1% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUVEN LIFE has posted a net profit of Rs 252 m (down 27.1% YoY). Sales on the other hand came in at Rs 1 bn (down 21.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Oct 18, 2019 (Close)

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES 5-YR ANALYSIS

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS